These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 37531380)

  • 1. Characterisation of putative class 1A DHODH-like proteins from Mucorales and dematiaceous mould species.
    Pinder C; Lebedinec R; Levine TP; Birch M; Oliver JD
    PLoS One; 2023; 18(8):e0289441. PubMed ID: 37531380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olorofim Effectively Eradicates Dermatophytes
    Mirbzadeh Ardakani E; Sharifirad A; Pashootan N; Nayebhashemi M; Zahmatkesh M; Enayati S; Razzaghi-Abyaneh M; Khalaj V
    Antimicrob Agents Chemother; 2021 Nov; 65(12):e0138621. PubMed ID: 34570652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olorofim Susceptibility Testing of 1,423 Danish Mold Isolates Obtained in 2018-2019 Confirms Uniform and Broad-Spectrum Activity.
    Astvad KMT; Jørgensen KM; Hare RK; Datcu R; Arendrup MC
    Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33020160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Dynamic Influence of Olorofim (F901318) on the Cell Morphology and Organization of Living Cells of
    du Pré S; Birch M; Law D; Beckmann N; Sibley GEM; Bromley MJ; Read ND; Oliver JD
    J Fungi (Basel); 2020 Apr; 6(2):. PubMed ID: 32290206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dihydroorotate dehydrogenase inhibitor olorofim has potent in vitro activity against Microascus/Scopulariopsis, Rasamsonia, Penicillium and Talaromyces species.
    Wiederhold NP; Patterson HP; Sanders CJ; Cañete-Gibas C
    Mycoses; 2023 Mar; 66(3):242-248. PubMed ID: 36435987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revisiting the role of dihydroorotate dehydrogenase as a therapeutic target for cancer.
    Madak JT; Bankhead A; Cuthbertson CR; Showalter HD; Neamati N
    Pharmacol Ther; 2019 Mar; 195():111-131. PubMed ID: 30347213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of olorofim against clinical isolates of the Fusarium oxysporum and Fusarium solani species complexes.
    Badali H; Cañete-Gibas C; Patterson H; Sanders C; Mermella B; Garcia V; Mele J; Fan H; Wiederhold NP
    Mycoses; 2021 Jul; 64(7):748-752. PubMed ID: 33755988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two different dihydroorotate dehydrogenases from yeast Saccharomyces kluyveri.
    Zameitat E; Knecht W; Piskur J; Löffler M
    FEBS Lett; 2004 Jun; 568(1-3):129-34. PubMed ID: 15196933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of the Novel Investigational Antifungal Olorofim.
    Wiederhold NP
    J Fungi (Basel); 2020 Jul; 6(3):. PubMed ID: 32751765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vitro Activity of Novel Antifungal Olorofim against Filamentous Fungi and Comparison to Eight Other Antifungal Agents.
    Georgacopoulos O; Nunnally NS; Ransom EM; Law D; Birch M; Lockhart SR; Berkow EL
    J Fungi (Basel); 2021 May; 7(5):. PubMed ID: 34065811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Dihydroorotate Dehydrogenase Inhibitors Using the Cell Painting Assay.
    Schölermann B; Bonowski J; Grigalunas M; Burhop A; Xie Y; Hoock JGF; Liu J; Dow M; Nelson A; Nowak C; Pahl A; Sievers S; Ziegler S
    Chembiochem; 2022 Nov; 23(22):e202200475. PubMed ID: 36134475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a biomarker to monitor target engagement after treatment with dihydroorotate dehydrogenase inhibitors.
    Pontikos MA; Leija C; Zhao Z; Wang X; Kilgore J; Tornesi B; Adenmatten N; Phillips MA; Williams NS
    Biochem Pharmacol; 2022 Oct; 204():115237. PubMed ID: 36055381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional expression of human dihydroorotate dehydrogenase (DHODH) in pyr4 mutants of ustilago maydis allows target validation of DHODH inhibitors in vivo.
    Zameitat E; Freymark G; Dietz CD; Löffler M; Bölker M
    Appl Environ Microbiol; 2007 May; 73(10):3371-9. PubMed ID: 17369345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Madurella mycetomatis, the main causative agent of eumycetoma, is highly susceptible to olorofim.
    Lim W; Eadie K; Konings M; Rijnders B; Fahal AH; Oliver JD; Birch M; Verbon A; van de Sande W
    J Antimicrob Chemother; 2020 Apr; 75(4):936-941. PubMed ID: 31904836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein-lipid interactions of human dihydroorotate dehydrogenase and three mutants associated with Miller syndrome.
    Orozco Rodriguez JM; Wacklin-Knecht H; Knecht W
    Nucleosides Nucleotides Nucleic Acids; 2022; 41(12):1337-1358. PubMed ID: 35184687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dihydroorotate dehydrogenase inhibitor olorofim exhibits promising activity against all clinically relevant species within Aspergillus section Terrei.
    Lackner M; Birch M; Naschberger V; Grässle D; Beckmann N; Warn P; Gould J; Law D; Lass-Flörl C; Binder U
    J Antimicrob Chemother; 2018 Nov; 73(11):3068-3073. PubMed ID: 30351438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Trypanosoma brucei dihydroorotate dehydrogenase as a possible drug target; structural, kinetic and RNAi studies.
    Arakaki TL; Buckner FS; Gillespie JR; Malmquist NA; Phillips MA; Kalyuzhniy O; Luft JR; Detitta GT; Verlinde CL; Van Voorhis WC; Hol WG; Merritt EA
    Mol Microbiol; 2008 Apr; 68(1):37-50. PubMed ID: 18312275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of pyrimidine biosynthesis targets protein translation in acute myeloid leukemia.
    So J; Lewis AC; Smith LK; Stanley K; Franich R; Yoannidis D; Pijpers L; Dominguez P; Hogg SJ; Vervoort SJ; Brown FC; Johnstone RW; McDonald G; Ulanet DB; Murtie J; Gruber E; Kats LM
    EMBO Mol Med; 2022 Jul; 14(7):e15203. PubMed ID: 35514210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the de novo pyrimidine biosynthesis pathway limits ribosomal RNA transcription causing nucleolar stress in glioblastoma cells.
    Lafita-Navarro MC; Venkateswaran N; Kilgore JA; Kanji S; Han J; Barnes S; Williams NS; Buszczak M; Burma S; Conacci-Sorrell M
    PLoS Genet; 2020 Nov; 16(11):e1009117. PubMed ID: 33201894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein production, kinetic and biophysical characterization of three human dihydroorotate dehydrogenase mutants associated with Miller syndrome.
    Orozco Rodriguez JM; Krupinska E; Wacklin-Knecht H; Knecht W
    Nucleosides Nucleotides Nucleic Acids; 2022; 41(12):1318-1336. PubMed ID: 35094635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.